Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and B16 Melanoma

1,3-dipropyl-8-cyclopentylxanthine has been researched along with B16 Melanoma in 2 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Woodhouse, EC1
Amanatullah, DF1
Schetz, JA1
Liotta, LA1
Stracke, ML1
Clair, T1
Merighi, S1
Varani, K1
Gessi, S1
Cattabriga, E1
Iannotta, V1
Ulouglu, C1
Leung, E1
Borea, PA1

Other Studies

2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and B16 Melanoma

ArticleYear
Adenosine receptor mediates motility in human melanoma cells.
    Biochemical and biophysical research communications, 1998, May-29, Volume: 246, Issue:3

    Topics: Adenosine; Adenosine Monophosphate; Animals; Chemotaxis; CHO Cells; Cricetinae; Dose-Response Relati

1998
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line.
    British journal of pharmacology, 2001, Volume: 134, Issue:6

    Topics: Adenosine Deaminase; Binding, Competitive; Calcium; Cell Membrane; Cyclic AMP; Humans; Melanoma, Exp

2001